Trial intelligence / Profile preview

Surgery vs Botulinum Toxin for Post-Stroke Spasticity

NCT06392633Recruiting

Sponsor
Fundación para la Investigación Biosanitaria de Andalucía Oriental
Start
Jan 2021
Primary completion
Jun 2024
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by Fundación para la Investigación Biosanitaria de Andalucía Oriental. Primary endpoints: 36-Item Short Form Survey Instrument at 12 months and Newcastle Stroke-Specific Quality of Life Measure at 12 months. Started Jan 2021; status: recruiting.

Beyond the preview

Go deeper on NCT06392633.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06392633.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call